16.298.684 News
7.688 Feeds
1.496 media
Get the latest worldwide news online on newspeg.com. News are classified by topic.
You are here : Home / Health / Disease / Physical / Liver disease / Final Results Of Ideal Study Presented At Annual Meeting Of The E...
Liver disease
Final Results Of Ideal Study Presented At Annual Meeting Of The European Association For The Study Of The Liver (EASL) - Medical News Today - 04/27/2008 09:04
Final results of the IDEAL study, the first large, randomized, clinical study comparing the leading therapies for chronic hepatitis C, were presented at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), providing important insights that may help guide clinical practice for physicians worldwide treating this... > Full news
Similar News
- Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO(R) - 06/30/2008 - Medical News Today
- ThermoDox In Combination With Radio Frequency Ablation Liver Phase I Results Presented At WCIO 2008 & Best Of ASCO - 06/29/2008 - Medical News Today
- Interim Results From Boceprevir Phase II Study In Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL - 04/27/2008 - Medical News Today
- Three Studies Presented At 43rd EASL Showed Higher SVR For PEGASYS(R) (Peginterferon Alfa-2a) Plus Ribavirin Than Peginterferon Alfa-2b Plus Ribavirin - 04/27/2008 - Medical News Today
- Biolex Therapeutics Researchers Present Locteron(R) Phase 2a Hepatitis C Trial Results At EASL Conference - 04/25/2008 - Medical News Today
- Data On Investigational Compounds Being Co-Developed By Tibotec For The Treatment Of Chronic Hepatitis C Presented At EASL 2008 - 04/25/2008 - Medical News Today
- Positive Findings In Treating Patients With Advanced Hepatitis C - 04/25/2008 - Medical News Today
- Valeant Pharmaceuticals Highlights Taribavirin Phase IIb Data Presentation At European Association For The Study Of Liver (EASL) Annual Meeting - 04/25/2008 - Medical News Today
- NAFLD AND NASH Linked To Metabolic Syndrome And Cardiovascular Disease - 04/25/2008 - Medical News Today
- Antipodean Pharmaceuticals Announces Results Of Phase 2 Study Of Lead Compound MitoQ(R) - 04/25/2008 - Medical News Today
Comments
You need to be logged to send comments

English
Print
Comment
0 Comments